MAINTAINING THE INVESTIGATOR’S STUDY FILE

Slides:



Advertisements
Similar presentations
Briefing on MHRA routine inspection of non-commercial clinical trials
Advertisements

Essential Documentation GCP Training Seminar 12th October 2011
Tips to a Successful Monitoring Visit
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Research and Development Department A Quick Guide to Using EDGE v2 for Researchers Version 1.2 – 23 February
Managing Regulatory Documents Electronically
CRC Protocol Documents Protocol Submissions Amendments Publications Study Closure.
Practical Effective Steps to Improve Trial QUALITY from Audit/Inspections findings Cancer Clinical Trials Unit Scotland A NCRI Accredited Cancer Trials.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Managing Sponsorship Research Services University of Oxford.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
PiPS Training Using the Randomisation Program Fiona Stacey PiPS Research Nurse Trial of probiotic to prevent necrotising entrocolitis and infection.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
Sponsor Visits and Monitoring
Welcome. Registration complete? CQC Inspection visit Routine Responsive Themed.
Office of Human Research (OHR) Quality Improvement Program Patrick Herbison Heather Krupinski.
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Briefing on MHRA routine inspection of non-commercial clinical trials
THE TRIAL DATABASE AND ONLINE DATA QUERIES
RATIONALE AND OVERVIEW
SchoolSuccess for Coordinators
HOW TO TRAIN PATIENTS ON COMPLETING THE QUESTIONNAIRES
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
REPORTING ADVERSE EVENTS AND COMPLETING THE REPORT FORM
The Role and Responsibilities of the Clinical Research Coordinator
HOW TO SEARCH MEDICAL RECORDS IN EMIS?
Responsibilities of Sponsor, Investigator and Monitor
HOW TO ENTER EARLY WITHDRAWAL DATA
Safety Reporting V6.0 17/01/17.
CONDUCTING THE TRIAL AT
HOW TO ENTER END OF TRIAL DATA
MAINTAINING THE INVESTIGATOR’S SITE FILE
Taking informed consent and withdrawal
Investigator of Record – Definition
HOW TO ENTER BASELINE DATA
DATABASE SEARCH & REVIEW GETTING STARTED GUIDE FOR EMIS WEB USERS
HOW TO CONSENT A PATIENT?
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Good Clinical Practice (GCP) requirements for ANODE
The early use of Antibiotics in at Risk CHildren with InfluEnza
Briefing Session Guide
Elements of an Organized Regulatory Binder
Flu Vaccine Booking Guidance 20-Nov-18.
RATIONALE AND OVERVIEW
HOW TO ENTER BASELINE DATA
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
THE OPTIONAL GENETIC STUDY
HOW TO CONSENT A PATIENT?
HOW TO ENTER EARLY WITHDRAWAL DATA
Investigator of Record – Definition
HOW TO TRAIN PATIENTS ON COMPLETING THE QUESTIONNAIRES
Investigator of Record – Definition
CONDUCTING THE TRIAL AT
HOW TO SEARCH MEDICAL RECORDS IN EMIS?
HOW TO ENTER END OF TRIAL DATA
WHAT TO DO IF A PATIENT DEVELOPS AN UNEXPECTED PROBLEM?
THE TRIAL DATABASE AND ONLINE DATA QUERIES
Understanding the Process of Documenting Informed Consent
Site File Management. Julie James, Aldona Kirkham Anne Moore UHL Clinical Trial Monitors and Trainers Sept 2017.
Good clinical practice
Presentation transcript:

MAINTAINING THE INVESTIGATOR’S STUDY FILE Trial protocol code: ISRCTN30952488 Version 2, 21 Nov 2017

Your Investigator Study File (ISF) Sent when all the necessary approvals / agreements are in place at your practice Contains all the information you need to conduct the trial, including training materials Ensures all study related documents are filed together Documents will demonstrate your compliance with the protocol, GCP, regulatory requirements Familiarise yourself with the contents of all sections, so you know where to find the information when needed Please return the receipt inside the front cover

Investigator Study File Keep in a secure location Must be accessible to the site trial staff It is a legal requirement to keep the study file up to date Must be available for monitoring visits by the CTU and any relevant regulatory authorities

Maintaining the ISF Ensure all logs are up to date: Site responsibility delegation log Training log Screening log Randomisation log Site visit log Final study results requested by patients Ensure all documents (consent forms, data forms, reports, communication with the CTU, etc) are filed regularly Archive all study documents for 5 years.

Site responsibility delegation log This log is contained in Folder 2, Section 17 “Site responsibilities” of the ISF List all members of site trial staff involved in the conduct of the trial e.g. doctors, nurses, practice managers, administrators (send copy to CTU) Add new staff members when they join the trial team (send copy to CTU) Note the end date for those who leave (send copy to CTU) When a team member leaves the trial, ensure they are replaced with a new team member and trained for their allocated tasks A brief CV (signed and dated) for each person listed on the log is required to be filed in section 17 (send copy to CTU)

Patient screening log This log is contained in Folder 2, Section 14 “Patient Entry” of the ISF The screening log keeps a record of all patients who express an interest in the StatinWISE trial This log is pre-populated with screening IDs If more screening logs are required, please contact the CTU

Randomisation log This log is contained in Folder 2, Section 14 “Patient Entry” of the ISF Use to document patients randomised into the StatinWISE trial Must be updated after each randomisation A patient is considered randomised when the database generates the randomisation number Randomisation number is the patients Study ID for the duration of the trial Randomisation number forms part of the Treatment Pack Number

Site visit log This log is contained in Folder 1, Section 12 “Trial Monitoring” of the ISF Update every time there is a trial related visit to your site i.e. CTU representative or regulatory body The reason for the visit might be site training, planned monitoring visit, triggered monitoring visit, sponsor or regulatory audit

Final study results log This log is contained in Folder 2, Section 18 “Reports” of the ISF Ask patients you have considered for participation if they or their relatives wish to receive a copy of the final trial full results If so, record the contact details on this form At the end of the trial the PI or CTU will post copies of the final report to the addresses entered

Trial and trial procedure materials Additional materials may be requested at any time The ProtocoL The copy for you and your team to use is inside the front cover of Folder 1 of the ISF The copy in Section 2 must not be removed from the ISF The Protocol contains the Summary of Product Characteristics (SmPC) for atorvastatin (the trial drug). The SmPC is the guidelines on the use of atorvastatin that have been approved by the UK regulatory agency (the MHRA) Manual of Operating Procedures (MOP) Can be found in Folder 1, Section 3 “Training Materials” of the ISF Contains detailed guidance on the practical conduct of the trial

Training materials INVESTIGATIONAL MEDICINAL PRODUCT DOSSIER (IMPD) Contains all the information relating to the IMP and the placebo GOOD CLINICAL PRACTICE Full training available (for free) on the Sponsor’s website: http://open.lshtm.ac.uk/enrol/index.php?id=6 StatinWISE WEBSITE Statinwise.lshtm.ac.uk You can find all the training presentations, updates about the trial, newsletters and recruitment figures

Training materials POWERPOINT PRESENTATIONS ON CD Front cover of the Site File Cover various aspects of the trial: Rationale and Overview Conducting the trial at your site The optional Genetic study Maintaining your Investigator Site File How to search medical records? How to screen patients and book the Baseline visit appointment? How to consent patients? The trial database and data queries? How to enter Baseline data? How to enter Early Withdrawal data? How to enter End of Trial data? How to train patients on completing the questionnaires? How to complete the questionnaires online? How to complete the questionnaires on the mobile app? How to complete the questionnaires on paper? How to complete the questionnaires by phone? What to do if a patient develops an unexpected problem? Reporting Adverse Events

CONTACT US London School of Hygiene & Tropical Medicine Room 180, Keppel Street, London WC1E 7HT Tel +44(0)20 7299 4684 Fax +44(0)20 7299 4663 Email: statinwise@Lshtm.ac.uk